Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merfol Healthcare is a pharmaceutical and nutraceutical company primarily focused on the development and commercialization of specialized folate-based therapies. The company is best known for its products containing L-methylfolate, the bioactive form of folic acid, which is used to address folate deficiencies and metabolic disorders related to the MTHFR gene mutation. Merfol's portfolio targets therapeutic areas such as obstetrics, gynecology, and psychiatry, providing solutions for hyperhomocysteinemia and as an adjunct therapy for major depressive disorder. The company operates primarily in the Indian market, offering a range of branded formulations designed to improve bioavailability and patient outcomes in nutritional health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Merfol.